Diverse effects of anti‐CD44 antibodies on the stromal cell‐mediated support of normal but not leukaemic (CML) haemopoiesis in vitro

We have identified three non‐cross‐reacting anti‐human CD44 monoclonal antibodies that have significant positive or negative (or no) effects on normal human haemopoiesis in the long‐term culture (LTC) system. These effects manifested as increases or decreases in the number of LTC‐initiating cells (LTC‐IC), and the number of colony‐forming cells (CFC) recovered from cultures in which either unseparated or highly purified CD34+CD38− normal marrow cells were placed on pre‐established normal marrow feeder layers in the presence or absence of each antibody. The effects seen were rapid and sustained, and dependent on the presence of a preformed feeder layer. Interestingly, the same anti‐CD44 antibodies had no effect on the maintenance of leukaemic (Ph+) progenitors (from patients with chronic myeloid leukaemia) when these cells were cultured on preformed feeder layers established from normal marrow. CD44 appears to be part of a mechanism by which stromal elements can regulate primitive normal haemopoietic cells but not their leukaemic (Ph+) counterparts.

[1]  S. Ghaffari,et al.  Altered patterns of CD44 epitope expression in human chronic and acute myeloid leukemia. , 1996, Leukemia.

[2]  P. Lansdorp,et al.  Characterization of primitive subpopulations of normal and leukemic cells present in the blood of patients with newly diagnosed as well as established chronic myeloid leukemia. , 1996, Blood.

[3]  J. Lévesque,et al.  CD44 and hyaluronan binding by human myeloid cells. , 1996, Leukemia & lymphoma.

[4]  C. Eaves,et al.  Self-renewal of primitive human hematopoietic cells (long-term-culture-initiating cells) in vitro and their expansion in defined medium. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[5]  S. Zigmond,et al.  Signal transduction and actin filament organization. , 1996, Current opinion in cell biology.

[6]  B. Sandmaier,et al.  An antibody to CD44 enhances hematopoiesis in long-term marrow cultures. , 1996, Experimental hematology.

[7]  M. Glimcher,et al.  Receptor-Ligand Interaction Between CD44 and Osteopontin (Eta-1) , 1996, Science.

[8]  R. Oostendorp,et al.  Adhesion of human hematopoietic progenitor cells to bone-marrow-derived stromal cells is enhanced by antibodies to CD44. , 1996, Acta haematologica.

[9]  C. Eaves,et al.  Quantitation of the quiescent fraction of long-term culture-initiating cells in normal human blood and marrow and the kinetics of their growth factor-stimulated entry into S-phase in vitro. , 1995, Blood.

[10]  P. Lansdorp,et al.  Differentiation-associated changes in CD44 isoform expression during normal hematopoiesis and their alteration in chronic myeloid leukemia. , 1995, Blood.

[11]  A. Gotoh,et al.  Tyrosine phosphorylation and activation of focal adhesion kinase (p125FAK) by BCR-ABL oncoprotein. , 1995, Experimental hematology.

[12]  R. Oostendorp,et al.  VLA‐4 and VCAM‐1 are the principal adhesion molecules involved in the interaction between blast colony‐forming cells and bone marrow stromal cells , 1995, British journal of haematology.

[13]  S. Lo,et al.  Increased tyrosine phosphorylation of focal adhesion proteins in myeloid cell lines expressing p210BCR/ABL. , 1995, Oncogene.

[14]  Q. He,et al.  Monoclonal antibodies to CD44 and their influence on hyaluronan recognition , 1995, The Journal of cell biology.

[15]  A. Droll,et al.  Adhesive interactions between alternatively spliced CD44 isoforms , 1995, Journal of Biological Chemistry.

[16]  H. Sorimachi,et al.  A Novel Ligand for CD44 Is Serglycin, a Hematopoietic Cell Lineage-specific Proteoglycan , 1995, The Journal of Biological Chemistry.

[17]  A. Droll,et al.  Regulation of the Functional Activity and Ligand Binding Specificity of the Adhesion Protein CD44 , 1995 .

[18]  G. Sauvageau,et al.  Differential expression of homeobox genes in functionally distinct CD34+ subpopulations of human bone marrow cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[19]  C. Verfaillie,et al.  Adhesion of committed human hematopoietic progenitors to synthetic peptides from the C-terminal heparin-binding domain of fibronectin: cooperation between the integrin alpha 4 beta 1 and the CD44 adhesion receptor. , 1994, Blood.

[20]  C. Verfaillie,et al.  Interferon-alpha restores normal adhesion of chronic myelogenous leukemia hematopoietic progenitors to bone marrow stroma by correcting impaired beta 1 integrin receptor function. , 1994, The Journal of clinical investigation.

[21]  I. Stamenkovic,et al.  Identification of hyaluronic acid binding sites in the extracellular domain of CD44 , 1993, Journal of Cell Biology.

[22]  P. Kincade,et al.  CD44 and its interaction with extracellular matrix. , 1993, Advances in immunology.

[23]  C. Eaves,et al.  The biology of normal and neoplastic stem cells in CML. , 1993, Leukemia & lymphoma.

[24]  C. Verfaillie,et al.  Mechanisms underlying abnormal trafficking of malignant progenitors in chronic myelogenous leukemia. Decreased adhesion to stroma and fibronectin but increased adhesion to the basement membrane components laminin and collagen type IV. , 1992, The Journal of clinical investigation.

[25]  H. Nakauchi,et al.  Expression and function of adhesion molecules on human hematopoietic stem cells: CD34+ LFA-1- cells are more primitive than CD34+ LFA-1+ cells. , 1992, Blood.

[26]  E. Butcher,et al.  The hyaluronate receptor is a member of the CD44 (H-CAM) family of cell surface glycoproteins [published erratum appears in J Cell Biol 1991 Feb;112(3):following 513] , 1990, The Journal of cell biology.

[27]  K. Miyake,et al.  Monoclonal antibodies to Pgp-1/CD44 block lympho-hemopoiesis in long- term bone marrow cultures , 1990, The Journal of experimental medicine.

[28]  P. Lansdorp,et al.  Characterization and partial purification of human marrow cells capable of initiating long-term hematopoiesis in vitro. , 1989, Blood.

[29]  M. Greaves,et al.  Altered adhesive interactions with marrow stroma of haematopoietic progenitor cells in chronic myeloid leukaemia , 1987, Nature.